Table 1.
Patient's laboratory data at the point of post-COVID-19 interstitial lung disease onset.
| Hematology | Case 1 | Case 2 | Case 3 | Biochemistry | Case 1 | Case 2 | Case 3 | Immunology | Case 1 | Case 2 | Case 3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WBC (/μL) | 11930 | 14670 | 8800 | AST (IU/L) | 110 | 18 | 24 | CRP (mg/dl) | 14.09 | 20.73 | 4.84 |
| Neut | 89.3% | 80.6% | 70.3% | ALT (IU/L) | 154 | 35 | 23 | KL-6 (U/L) | 1462 | 595 | 4680 |
| Lym | 5.6% | 7.4% | 12.1% | ALP (IU/L) | 481 | 216 | 280 | SP-D (ng/ml) | 161 | N/M | 482 |
| Mo | 4.1% | 11.2% | 11.2% | LDH (IU/L) | 336 | 239 | 343 | IgA (mg/dl) | 314 | 444 | 566 |
| Eo | 0.5% | 0.5% | 5.9% | BUN (mg/dl) | 10 | 14 | 12 | IgG (mg/dl) | 1260 | 940 | 1208 |
| Baso | 0.5% | 0.3% | 0.5% | Cr (mg/dl) | 0.65 | 0.77 | 0.64 | IgM (mg/dl) | 73 | 91 | 77 |
| RBC (X106/μL) | 398 | 405 | 463 | CK (IU/L) | 66 | 23 | 44 | C3 (mg/dl) | 185 | 163 | 141 |
| Hb (g/dL) | 11.7 | 12.3 | 14.7 | TP (g/dl) | 6.5 | 6.4 | 6.7 | C4 (mg/dl) | 41 | 34 | 20 |
| Ht | 36.0% | 38.0% | 43.6% | Alb (g/dl) | 2.6 | 2.7 | 2.8 | Complement, Total (CH50/mL) | 29.0 | 48.8 | 48.4 |
| Plt (X103/μL) | 131 | 232 | 257 | Ferritin (ng/ml) | 721 | N/M | 1285 | RF (U/mL) | 3 | 6 | 4 |
| Na (mEq/l) | 137 | 127 | 137 | C-ANCA (U/mL) | 1.0 | 2.1 | 1.0 | ||||
|
Coagulation |
K (mEq/l) | 3.7 | 4.3 | 3.9 | MPO-ANCA (U/mL) | 1.0 | 1.0 | 1.0 | |||
| PT (sec) | 11.9 | N/M | 11.7 | Cl (mEq/l) | 100 | 94 | 99 | Antinuclear antibodies | Neg | Neg | Neg |
| APTT (sec) | 36.4 | N/M | 29.3 | Ca (mg/dl) | 8.8 | 8.3 | 9.3 | ||||
| D-Dimer (ng/ml) | 2.6 | N/M | 1.3 | FBS (mg/dl) | 126 | 238 | 106 |
Auto-Antibody, Names |
|||
| HbA1c (%, NGSP) | 6.8 | 8.2 | 7.6 | ARS | Neg | Neg | Neg | ||||
| NT-pro BNP (pg/ml) | 517 | N/M | 397 | Centromere | Neg | Neg | Neg | ||||
| Scl-70 | Neg | Neg | Neg | ||||||||
| Sm | Neg | Neg | Neg | ||||||||
| RNP | Neg | Neg | Neg | ||||||||
| CCP (U/ml) | 0.6 | 0.6 | 0.6 |
N/M; not measured, Neg; Negative, ARS; aminoacyl tRNA synthetase, RNP; ribonucleoprotein, CCP; cyclic citrullinated peptide.